IDEAYA Biosciences Cash from Investing (Quarterly) Trends

IDEAYA Biosciences Inc (IDYA)

26.79 +0.19 (+0.71%) USD | NASDAQ | Nov 22, 16:00

26.77 -0.02 (-0.07%) After-Hours: 20:00

Cash from Investing (Quarterly) Chart

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
September 30, 2024	-20.04M
June 30, 2024	68.56M
March 31, 2024	-353.97M
December 31, 2023	-111.94M
September 30, 2023	51.35M
June 30, 2023	-121.38M
March 31, 2023	23.52M
December 31, 2022	-10.28M
September 30, 2022	-18.68M
June 30, 2022	13.32M
March 31, 2022	-17.76M
December 31, 2021	-0.413M
September 30, 2021	-56.31M
June 30, 2021	-49.38M

Date	Value
March 31, 2021	36.44M
December 31, 2020	-4.554M
September 30, 2020	-183.58M
June 30, 2020	30.99M
March 31, 2020	10.91M
December 31, 2019	3.887M
September 30, 2019	-38.44M
June 30, 2019	11.41M
March 31, 2019	25.41M
December 31, 2018	6.576M
September 30, 2018	5.261M
June 30, 2018	-14.52M
March 31, 2018	-60.49M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

-353.97M

Minimum

Mar 2024

68.56M

Maximum

Jun 2024

-35.47M

Average

-7.415M

Median

Cash from Investing (Quarterly) Benchmarks

Gilead Sciences Inc	-710.00M
Vertex Pharmaceuticals Inc	-348.00M
Black Diamond Therapeutics Inc	2.193M
NovaBay Pharmaceuticals Inc	-0.002M
Palatin Technologies Inc	0.00

Cash from Investing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-49.23M
Cash from Financing (Quarterly)	286.50M
Free Cash Flow	-153.27M
Free Cash Flow Per Share (Quarterly)	-0.5765
Free Cash Flow Yield	-7.51%